HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $397,204 | +12.0% | 3,433,349 | -0.4% | 0.68% | +32.5% |
Q2 2023 | $354,704 | -3.5% | 3,448,749 | +2.4% | 0.51% | +4.7% |
Q1 2023 | $367,633 | +92.9% | 3,368,449 | +101.1% | 0.49% | +87.0% |
Q4 2022 | $190,621 | -99.8% | 1,675,049 | +7.3% | 0.26% | +90.5% |
Q3 2022 | $96,639,000 | -30.4% | 1,561,466 | -10.3% | 0.14% | -16.5% |
Q2 2022 | $138,804,000 | -34.9% | 1,740,266 | -14.1% | 0.16% | -34.4% |
Q1 2022 | $213,131,000 | -13.1% | 2,025,766 | -11.0% | 0.25% | -18.0% |
Q4 2021 | $245,377,000 | -31.1% | 2,277,066 | -30.0% | 0.30% | -33.7% |
Q3 2021 | $356,165,000 | -10.2% | 3,251,463 | -23.3% | 0.46% | -7.1% |
Q2 2021 | $396,815,000 | -17.2% | 4,237,663 | -18.7% | 0.50% | -17.1% |
Q1 2021 | $479,525,000 | -3.6% | 5,209,963 | -23.4% | 0.60% | +10.6% |
Q4 2020 | $497,344,000 | -27.1% | 6,798,963 | -22.6% | 0.54% | -20.7% |
Q3 2020 | $682,098,000 | +19.0% | 8,780,875 | -14.9% | 0.68% | +37.6% |
Q2 2020 | $573,190,000 | +82.2% | 10,312,875 | -2.9% | 0.50% | +61.8% |
Q1 2020 | $314,673,000 | -13.9% | 10,623,675 | +5.2% | 0.31% | +8.9% |
Q4 2019 | $365,644,000 | +43.6% | 10,100,675 | +8.0% | 0.28% | +30.1% |
Q3 2019 | $254,616,000 | +20.9% | 9,350,575 | +6.8% | 0.22% | +16.8% |
Q2 2019 | $210,628,000 | – | 8,754,275 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |